Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5878 posts found.

UK and Polish regulatory authorities approve Akari Therapeutics’ higher-yielding manufacturing process

March 30, 2023 Manufacturing and Production

Akari Therapeutics has announced that the UK’s MHRA and the Polish Office for Registration of Medicinal Products, Medical Devices and …
News

Eli Lilly invests $1bn in Limerick manufacturing facilities

March 28, 2023 Manufacturing and Production

Pharma company Eli Lilly is increasing its investment in its new manufacturing facilities in Limerick, Republic of Ireland. Today’s announcement …
News

Moderna chooses Oxfordshire for new UK facility

March 6, 2023 Manufacturing and Production

US biotech firm Moderna has chosen Harwell Science Campus in Oxfordshire for its new UK R&D facility. The campus is …
News

REGENXBIO presents interim phase 2 data from drug developed on NAVXpress™ platform

February 13, 2023 Manufacturing and Production

REGENXBIO, a clinical-stage biotech company, has announced positive phase 2 data for their drug RXG-314, which was developed by the …
News

US Department of Justice asks Third Circuit to reinstate conspiracy charges again KVK

February 8, 2023 Manufacturing and Production

The US Department of Justice (DoJ) encouraged the Third Circuit to reinstate ‘conspiracy to defraud’ charges against Philadelphia-based generic drug …
News

Daiichi Sankyo to build Japan’s first factory for mRNA COVID-19 vaccines

February 6, 2023 Manufacturing and Production

Daiichi Sankyo have announced its plans to build Japan’s first factory for mRNA COVID-19 vaccines. The new facility is expected …
News

Eli Lilly plans to invest $450m at production site in Research Triangle Park

January 25, 2023 Manufacturing and Production

US-based pharmaceutical company, Eli Lilly and Company, has announced plans to invest $450m in its manufacturing facilities at Research Triangle …
News

Intas Pharmaceuticals under FDA scrutiny after oversight in GMP documents

January 20, 2023 Manufacturing and Production

India-based manufacturer Intas Pharmaceuticals has been issued a Form 483 by the FDA after three investigators found a “cascade of …
News

Johnson & Johnson scale back COVID-19 vaccination production

January 17, 2023 Manufacturing and Production

US-based Johnson & Johnson (J&J) have begun scaling back production of their COVID-19 vaccine due to demand falling over the …
News

$22m raised by PBS Biotech to expand single-use manufacturing products and services for cell therapy clients

January 9, 2023 Manufacturing and Production

PBS Biotech, an innovative, single-use bioreactor manufacturer and process development services provider, has worked together with Avego Management and BroadOak …
News

Sarepta Therapeutics and Catalent sign manufacturing deal for DMD gene therapy approval

January 9, 2023 Manufacturing and Production

Sarepta Therapeutics is a company focused on gene therapy, RNA and gene editing, engineering precision genetic medication for rare diseases. …
News

Sanofi plans eco-friendly additions to Brisbane manufacturing campus

January 6, 2023 Manufacturing and Production

Sanofi is aiming to expand its eco-friendly and renewable energy ecosystem with plans to install solar panels on the carpark, …
News

Moderna signs ten-year deal with UK Government for vaccine production

December 23, 2022 Manufacturing and Production

US biotech company Moderna has finalised a partnership with the UK government to produce vaccines, the main element of which …
News

Eli Lilly’s COVID-19 drug bebtelovimab loses FDA authorisation

December 1, 2022 Manufacturing and Production

The FDA have announced that Eli Lilly’s COVID-19 drug bebtelovimab is not authorised for emergency use in the US, as …
News

SMC accepts HRT treatment Bijuve for use across NHS Scotland

September 13, 2022 Manufacturing and Production

The SMC has accepted HRT treatment, Bijuve, for use across NHS Scotland. Bijuve is the first and only body-identical HRT …
News
The Gateway to Local Adoption Series

Latest content

AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials

October 4, 2026

Brenntag and dsm-firmenich expand biopharma vitamin partnership

October 4, 2026

CeramTec expands German production capacity for orthopaedic ceramics

October 2, 2026

Migraine annual economic and quality-of-life burden in UK

October 1, 2026

bit.bio expands human heart cell portfolio through myriamed partnership

September 30, 2026